- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Amy Crawford-Faucher Discusses the Future of Vaccination for COVID-19
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent reports from the World Health Organization about COVID-19.
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent new World Health Organization research on vaccine protection against COVID-19.
Transcript
A report from the World Health Organization found that people are having long-lasting protection against COVID-19 when they have been both vaccinated and infected up to 12 months after infection. How do you think that changes how COVID-19 is addressed by the primary care physician for both adults and children?
So I think that, clearly, the COVID situation has been evolving now for 3 years. And so that kind of fits our anecdotal evidence that if you had all the vaccines and the COVID infection that you seem pretty well protected. And if you get COVID again it tends to be mild. I certainly have patients who've gotten COVID, 3 times so far, and they're fully immunized and then folks who still haven't gotten it at all. So I do think, because so much of the population has had a COVID infection, that if we can maintain our COVID vaccination rates and booster rates, that if this evidence continues to bear out, I think that's really exciting, because I think that's how we get to a level of herd immunity that can make COVID eventually look more like flu. And could help kind of add credence to, you get your flu shot once a year, you get your COVID shot once a year.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
